BioNTech SE (BNTX) Reports Q1 EPS of EUR14.24, Reiterates FY22 Guidance

BioNTech SE (NASDAQ: BNTX) reported Q1 EPS of EUR14.24. Revenue for the quarter came in at EUR6.4 billion.

The company reiterated COVID-19 2022 vaccine revenue guidance of €13 billion to €17 billion.

For earnings history and earnings-related data on BioNTech SE (BNTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Sinda raises $331M in IPO, reports Q2 net loss of $16.6M